BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 177 filers reported holding BLUEBIRD BIO INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380 | -7.5% | 125 | 0.0% | 0.00% | – |
| Q2 2023 | $411 | +3.3% | 125 | 0.0% | 0.00% | – |
| Q1 2023 | $398 | -54.0% | 125 | 0.0% | 0.00% | – |
| Q4 2022 | $865 | -13.5% | 125 | -5.3% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | -66.7% | 132 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $3,000 | -25.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | +300.0% | 132 | +450.0% | 0.00% | +100.0% |
| Q4 2020 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,000 | -75.0% | 24 | -42.9% | 0.00% | -66.7% |
| Q3 2019 | $4,000 | -33.3% | 42 | -10.6% | 0.00% | -25.0% |
| Q2 2019 | $6,000 | -14.3% | 47 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $7,000 | -30.0% | 47 | -29.9% | 0.01% | 0.0% |
| Q3 2018 | $10,000 | – | 67 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |